Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2- mBC Patients With Multiple Metastatic Sites
Clinical Therapeutics, 2016 04; 38(4): 905-917. e-pub ahead of print 2016/03/08
Authors
Li N, Hao Y, Xie J, Lin PL, Koo V, Ohashi E, Wu EQ